Cargando…
Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells
The combined treatment with histone deacetylase inhibitors (HDACi) and retinoids has been suggested as a potential epigenetic strategy for the control of cancer. In the present study, we investigated the effects of treatment with butyrate, a dietary HDACi, combined with vitamin A on MCF-7 human brea...
Autores principales: | Andrade, F.O., Nagamine, M.K., De Conti, A., Chaible, L.M., Fontelles, C.C., Jordão Junior, A.A., Vannucchi, H., Dagli, M.L.Z., Bassoli, B.K., Moreno, F.S., Ong, T.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Medicina Tropical
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854326/ https://www.ncbi.nlm.nih.gov/pubmed/22714808 http://dx.doi.org/10.1590/S0100-879X2012007500103 |
Ejemplares similares
-
Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012) -
Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells
por: Li, Liping, et al.
Publicado: (2015) -
Expression of NR1I3 in mouse lung tumors induced by the tobacco-specific
nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone
por: Fukumasu, H., et al.
Publicado: (2015) -
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
por: Walsh, Michael E., et al.
Publicado: (2015) -
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
por: Chen, Yiming, et al.
Publicado: (2021)